Juno Therapeutics, A Subsidiary Of Celgene

This program gives people with large B-cell lymphoma access to a CAR T-cell therapy called lisocabtagene maraleucel (liso-cel) that didn't pass all quality checks. It's only for patients who were already prescribed liso-cel as part of their regular care. Participants receive chem…